Outcomes of Patients admitted with COVID pneumonia at 3 month follow up

Title: Outcomes of Patients admitted with COVID pneumonia at 3 month follow up
Author(s): Walsh S, Uno M, O’ Connor A, MacMahon C, Counihan I, Hassan T
Institution: Our Lady Of Lourdes Hospital, Drogheda, Co. Louth
Poster: Click to view poster
Category: COVID 19
Abstract: COVID-19 infection can produce long lasting symptoms that have debilitating symptoms impacting on quality of life. We present data from patients attending a dedicated COVID-19 follow up clinic.
796 patients required inpatient treatment for COVID pneumonia. 53% required supplemental oxygen, 37.8% required CPAP or high flow nasal oxygen therapy, 9% required ICU admission. Of these, 497 attended a post covid clinic (25.7% virtual, 74.3% in person review). 26 patients had CT imaging of the chest – 4 pulmonary emboli were found on 7 CTPAs, 3 had evidence of lung fibrosis, 4 had worsening ground glass opacification. 52 patients had Holter monitors with 42% showing persistent sinus tachycardia. Echocardiography and pulmonary functioning testing did not identify significant abnormalities between moderate and severe cases post discharge. Fatigue and anxiety scores were elevated at 3 months post discharge while 66% reported they had not returned to their premorbid level of functioning. 31% had Dysfunctional breathing based on Nijmegen questionnaire.
COVID-19 symptoms may persist beyond the acute hospital admission. Physiological measurements showed no difference in comparison between those requiring ICU admission or non-invasive respiratory support and those that did not 3 months post discharge. Dysfunctional breathing and anxiety were common following hospital admission for COIVD-19.